Related Experiment Video
Updated: Oct 18, 2025
A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
Serum biomarkers for chronic pancreatitis pain patterns
Jami L Saloman1, Gong Tang2, Kimberly M Stello3
1Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Pittsburgh, PA, USA; Pittsburgh Center for Pain Research, School of Medicine, University of Pittsburgh, PA, USA; Department of Neurobiology, School of Medicine, University of Pittsburgh, PA, USA.
Biomarkers in chronic pancreatitis (CP) serum associate with distinct pain patterns. Elevated IL-1β, IL-6, IL-2, TNFα, and MCP1 link to mild-moderate constant pain, while IL-4, IL-8, and CGRP suggest severe pain.
Area of Science:
- Gastroenterology and Hepatology
- Pain Medicine
- Biochemistry
Background:
- Chronic pancreatitis (CP) causes severe, refractory pain, necessitating better management strategies.
- Current pain characterization lacks mechanism-based tools for guiding treatment.
- Distinct pain subtypes exist, but their underlying biochemical basis is poorly understood.
Purpose of the Study:
- To investigate potential serum pain biomarkers in CP patients.
- To determine if these biomarkers correlate with specific pain patterns (severity and temporal nature).
- To explore the potential for developing mechanism-based pain management approaches.
Main Methods:
- Serum samples from 99 CP patients were analyzed for cytokines, chemokines, and peptides.
- Unsupervised hierarchical cluster analysis grouped patients by biomarker profiles.
- Classification and regression tree models assessed biomarker predictive power for pain outcomes.
Main Results:
- Patients with constant, mild-moderate pain showed elevated IL-1β, IL-6, IL-2, TNFα, and MCP1.
- Higher IL-4, IL-8, and CGRP levels were associated with severe pain.
- Constant pain correlated with reduced TNFα and fractalkine; severe pain with reduced TNFα, IL-6, and substance P.
Conclusions:
- Distinct biochemical signatures are linked to unique pain experiences in CP.
- These findings support the development of precision pain management strategies.
- Further research combining biochemical data and pain phenotyping is warranted.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...